Aperion is going public!
Find out how you can participate and invest in our A+ IPO
Available on demand,
when surgeons need it
Designed for improved acceptance by patients
Requires no changes to surgical technique, or rehabilitation
14 patents worldwide
CE Approved and
available for inquiry
"The premise of Aperion Biologics’ business is a bit of a no-brainer: Provide the market with a product used to repair anterior cruciate ligaments
"A San Antonio medical device company has filed papers with the Securities and Exchange Commission to raise $20 million under the federal governmen
San Antonio, TX, Sept 22, 2015 – For immediate release: Today Aperion Biologics, Inc.